Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/09/2003WO2003083105A1 Treatment and prevention of angiostenosis
10/09/2003WO2003083100A1 Expression of phospholipid:diacylglycerine acyltransferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
10/09/2003WO2003083098A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/09/2003WO2003083096A2 Cancer associated protein kinases and their uses
10/09/2003WO2003083093A1 Host cells having improved cell survival properties and methods to generate such cells
10/09/2003WO2003083087A1 Method and cloning vectors utilizing intergeneric conjugation for manipulation of actinomycetes biosynthesis genes
10/09/2003WO2003083086A2 High level expression of immunogenic proteins in the plastids of higher plants
10/09/2003WO2003083080A2 Mixed- cell gene therapy
10/09/2003WO2003083075A2 Retrovirus-based genomic screening
10/09/2003WO2003083069A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003WO2003083066A2 Methods for increasing polypeptide production
10/09/2003WO2003083065A2 Improved methods for achieving expression from alphavirus vectors
10/09/2003WO2003083059A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083057A2 Adipocytes and uses thereof
10/09/2003WO2003083056A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
10/09/2003WO2003083055A2 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
10/09/2003WO2003083053A2 Constructing very long dna sequences from synthetic dna molecules
10/09/2003WO2003083051A2 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083045A2 Lambda integrase mediated recombination in plants
10/09/2003WO2003083042A2 Pathogen-induced promoters
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003083038A2 Disruption of the redk gene
10/09/2003WO2003083037A2 Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082920A1 Chemokines and uses thereof
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082917A1 Novel polypeptide and nucleic acid encoding the same
10/09/2003WO2003082913A1 Genes from drought stress tolerant tea plant and a method of introducing water-stress tolerance
10/09/2003WO2003082912A2 Transgenic plants expressing mussel adhesive proteins
10/09/2003WO2003082911A2 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
10/09/2003WO2003082910A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003WO2003082905A1 Plant retroviral polynucleotides and methods for use thereof
10/09/2003WO2003082899A2 Compositions and methods for altering tocotrienol content
10/09/2003WO2003082892A1 Improved apparatus, methods and compositions for biotechnical separations
10/09/2003WO2003082809A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
10/09/2003WO2003082370A2 Transcellular drug delivery system
10/09/2003WO2003082346A1 Recombinant chimeric protein for the target delivery of dna to eukariotic target cells
10/09/2003WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
10/09/2003WO2003082344A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
10/09/2003WO2003082331A1 Decoy compositions for treating and preventing brain diseases and disorders
10/09/2003WO2003082330A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082255A2 Use of mob-5 in pain
10/09/2003WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003WO2003082200A2 Potent oncolytic herpes simplex virus for cancer therapy
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082195A2 Protamine-adenoviral vector complexes and methods of use
10/09/2003WO2003082184A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003WO2003082006A2 Methods and compositions for preventing obesity and obesity related disorders
10/09/2003WO2003081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
10/09/2003WO2003081996A2 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
10/09/2003WO2003081993A2 Transgenic aves producing human polyclonal antibodies
10/09/2003WO2003081992A2 The functional disruption of avian immunoglobulin genes
10/09/2003WO2003081990A2 Improved method for generating genetically modified animals
10/09/2003WO2003081988A2 Generation of plants with improved drought tolerance
10/09/2003WO2003081978A2 Generation of plants with improved pathogen resistance
10/09/2003WO2003057731A3 Human pheromone receptors
10/09/2003WO2003052132A3 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
10/09/2003WO2003052115A3 Post-synthesis labeling of nucleic acids and uses thereof
10/09/2003WO2003048325A3 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in genetic transformation technology
10/09/2003WO2003048315A3 Antisense modulation of mdm2 expression
10/09/2003WO2003040378A8 Method of plant transformation
10/09/2003WO2003040303A3 Functional assay for agonist activation of receptors
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003035856A3 Protein with kinase activity
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003032923A3 Induction of beta cell differentiation in human cells
10/09/2003WO2003031054A3 Arrays having clustered arrangements and methods of making and using them
10/09/2003WO2003028661A3 Adjuvanted meningococcus compositions
10/09/2003WO2003028621A3 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
10/09/2003WO2003028432A3 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
10/09/2003WO2003024389A3 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003020928A3 Identification of eukaryotic internal ribosome entry site (ires) elements
10/09/2003WO2003020758A3 Cdk regulator proteins called ringo
10/09/2003WO2003018787A3 Purified human hscas1 gene, polypeptides encoded by hscas1 for o-acetylation of sialic acids and for the diagnosis and prognosis of cancer
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003014149A3 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003013224A3 Herbicide tolerant cotton plants and methods for producing and identifying same
10/09/2003WO2003012116A3 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
10/09/2003WO2003008437A3 Protein and nucleic acid expression systems
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003003015A3 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002101353A3 Methods and products for analyzing nucleic acids based on methylation status
10/09/2003WO2002101023A3 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002090934A3 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
10/09/2003WO2002087503A3 Compositions and methods for treating colorectal polyps and cancer
10/09/2003WO2002083936A3 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/09/2003WO2002079505A3 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
10/09/2003WO2002072786A3 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon